Psivida wins technology award

By Melissa Trudinger
Thursday, 15 July, 2004

Nanotechnology company Psivida (ASX: PSD) has had its research applying its BioSilicon technology to drug delivery, diagnostics, orthopaedics and tissue engineering recognised with a 2004 Excellence in Research Award from US consulting group Frost & Sullivan.

Frost & Sullivan announced the award in a recently released study focusing on nanomedicine.

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...

Content from other channels on our network

Vaxxas secures TGA licence to manufacture vaccine patch technology

DroneShield nabs another European military contract

Daikin Australia opens new Sydney factory

AR3 to be first to process rare earths at ANSTO's new pilot facility

Defence Trailblazer funding manufacturing to help Defence and industry transition to clean energy

Four food safety tips for the silly season

Santa creates a spike in Australia's milk demand

Spicing up the festive season with Australian bushfood flavours

Kraft Heinz appoints Steve Cahillane as CEO

Irish drinks manufacturer takes its supply chain to the next level

Sustainability in 2026: what's next for Australian businesses?

How Australia can increase its circularity rate

$25m grant supports cleaner cement production

Bürkert team to take on sustainability strategies

ASC certifies NT barramundi farm